Clinical Trials
- Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR (PROGRESS)
- Ages65 years and older
- GenderBoth
- Heart/Cardiovascular
Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study. (DEFINE-TAVR)
- Heart/Cardiovascular
PROTECT H2H – Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Mental Health & Behavioral Research
An Intervention to Reduce Readmission Rates in Young Women with Acute Myocardial Infarction (AMI)
- Cancer
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (HEART)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)
- Ages18 years and older
- GenderBoth
- Diabetes
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
- Ages4 years - 17 years
- GenderBoth
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth
- Diabetes
Affordable Housing and Diabetes
- Ages18 years and older
- GenderBoth